RESULTS	At the final on-therapy evaluation , the mean HAM-D ( 17 ) scores for desvenlafaxine 100 mg/day ( 12.75 ) and 400 mg/day ( 12.50 ) were significantly lower than for placebo ( 15.31 ; p = .0038 and p = .0023 , respectively ) ; for desvenlafaxine 200 mg/day , the mean score was 13.31 ( p = .0764 ) .\